Interim report – third quarter of 2025
12 november, 08:00
12 november, 08:00
Interim report – third quarter of 2025
Wednesday, Schouw & Co. released its interim report for the third quarter of 2025; Schouw & Co. delivered an overall strong Q3 2025 performance in an environment marked by shifting uncertainties.
Highlights
Statement by Jens Bjerg Sørensen, President of Schouw & Co.
– The shifting uncertainties continued in the third quarter of 2025, but once again the conglomerate’s strength and diversified exposure proved its value. Market headwinds in the quarter in BioMar’s important Norwegian market is offset by continued strong progress in HydraSpecma and Fibertex Personal Care, and the consolidated profit in the quarter was in line with expectations. Investments remain at a controlled level and cash flow generation is attractive.
In Schouw & Co., we have used the current uncertain environment to prepare for a future characterised by volatility and challenges to global trade. We are optimising our global footprint and securing a long-term competitive cost base. This involves restructuring costs of almost DKK 100 million in 2025 but will significantly strengthen our position and platform.
We continue investigating whether a potential separate listing of BioMar would create value for the shareholders of Schouw & Co. and the process is progressing as expected. A value-creating IPO of BioMar is a natural consequence of our strategic approach to best-ownership and future-proofing and would leave Schouw & Co. in a strong position with an even healthier balance sheet. We expect to continue investing in our portfolio businesses and are also positive about the potential of expanding the portfolio with a new platform investment.
Video conference call (in English) in relation to the interim report
Please attend via this link: www.schouw.com/cc
Aktieselskabet Schouw & Co.
Jørgen Dencker Wisborg, Chairman
Jens Bjerg Sørensen, President, tel. +45 8611 22 22
Attachment

12 november, 08:00
Interim report – third quarter of 2025
Wednesday, Schouw & Co. released its interim report for the third quarter of 2025; Schouw & Co. delivered an overall strong Q3 2025 performance in an environment marked by shifting uncertainties.
Highlights
Statement by Jens Bjerg Sørensen, President of Schouw & Co.
– The shifting uncertainties continued in the third quarter of 2025, but once again the conglomerate’s strength and diversified exposure proved its value. Market headwinds in the quarter in BioMar’s important Norwegian market is offset by continued strong progress in HydraSpecma and Fibertex Personal Care, and the consolidated profit in the quarter was in line with expectations. Investments remain at a controlled level and cash flow generation is attractive.
In Schouw & Co., we have used the current uncertain environment to prepare for a future characterised by volatility and challenges to global trade. We are optimising our global footprint and securing a long-term competitive cost base. This involves restructuring costs of almost DKK 100 million in 2025 but will significantly strengthen our position and platform.
We continue investigating whether a potential separate listing of BioMar would create value for the shareholders of Schouw & Co. and the process is progressing as expected. A value-creating IPO of BioMar is a natural consequence of our strategic approach to best-ownership and future-proofing and would leave Schouw & Co. in a strong position with an even healthier balance sheet. We expect to continue investing in our portfolio businesses and are also positive about the potential of expanding the portfolio with a new platform investment.
Video conference call (in English) in relation to the interim report
Please attend via this link: www.schouw.com/cc
Aktieselskabet Schouw & Co.
Jørgen Dencker Wisborg, Chairman
Jens Bjerg Sørensen, President, tel. +45 8611 22 22
Attachment


Kinneviks VD slutar
Analyser
Börsen
USA

Kinneviks VD slutar
Analyser
Börsen
USA
OMX Stockholm 30
1 DAG %
Senast
2 699,35
